Centene Corp (CNC) stock

CNCNYSEHospital & Medical Service PlansFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 8/302% above fair value

$71.27+1.00 (+1.42%)

Close on Nov 13, 2026Market cap $35.28BP/E 24.4Yield –

Centene r&d expenses

Research and development expenses are spending on new products and technology.

Centene has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CNC.

Revenue growth9.7% · median 6.5%

Gross margin7.9% · median 54.6%

Operating margin0.5% · median 2.7%

Net margin0.7% · median 2.1%

Advertisement
300 × 250

See a number that looks wrong?